pharma

Zealand Pharma launches long-term incentive programs for Zealand Pharmas Board of Directors, Corporate Management and employees for 2025Zealand Pharma launches long-term incentive programs for Zealand Pharmas Board of Directors, Corporate Management and employees for 2025

Zealand Pharma launches long-term incentive programs for Zealand Pharmas Board of Directors, Corporate Management and employees for 2025

April 19, 2025 16:00 ET  | Source: Zealand Pharma Company announcement – No. 9 / 2025 Zealand Pharma launches long-term…

3 days ago
Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 ConferenceCocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference

BOTHELL, Wash., April 16, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, President and co-CEO,…

7 days ago
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 11, 2025 16:01 ET  | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio…

1 week ago
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down ActivitiesVincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities

SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated…

2 weeks ago
Respilean Drops Exposed (MUST-READ): The Truth About Lung Support Big Pharma Doesnt Want You to KnowRespilean Drops Exposed (MUST-READ): The Truth About Lung Support Big Pharma Doesnt Want You to Know

Respilean Drops Exposed (MUST-READ): The Truth About Lung Support Big Pharma Doesnt Want You to Know

JUPITER, FLORIDA, April 02, 2025 (GLOBE NEWSWIRE) --  RESPILEAN In a world where we measure everything—from step counts to calories—there’s…

3 weeks ago
Total number of shares and voting rights in Zealand Pharma as of March 31, 2025Total number of shares and voting rights in Zealand Pharma as of March 31, 2025

Total number of shares and voting rights in Zealand Pharma as of March 31, 2025

March 31, 2025 17:00 ET  | Source: Zealand Pharma Company announcement – No. 8 / 2025 Total number of shares…

3 weeks ago
NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease modelNMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease model

NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease model

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, TexasOral presentation included data from MuSK-MG…

4 weeks ago
Azurity Pharmaceuticals Completes Acquisition of Covis PharmaAzurity Pharmaceuticals Completes Acquisition of Covis Pharma

Azurity Pharmaceuticals Completes Acquisition of Covis Pharma

WOBURN, Mass., March 14, 2025 /PRNewswire/ -- Azurity Pharmaceuticals ("Azurity") announced today the successful completion of its acquisition of Covis Group S.à…

1 month ago
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patientsLaminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative cancer therapy based…

2 months ago
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic AlternativesVincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that the previously signed…

2 months ago